


Laureate Biopharmaceutical Services Revenue
Biotechnology Research • St Louis, Missouri, United States • 1-10 Employees
Laureate Biopharmaceutical Services revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at Laureate Biopharmaceutical Services
Mark Thomas
Associate Director Quality Technical Support
Company overview
| Headquarters | 4766 LaGuardia Dr, St. Louis, Missouri 63134, US |
| Website | |
| NAICS | 541714 |
| Keywords | Cgmp, Drug Substance Manufacturing, Cell Line Optimization, Single-Use Technologies, Formulation And Aseptic Filling, Protein Modification And Conjugation, Purification At Scale, Upstream & Downstream Process Development, 000L, Bioreactor Production From 20 To 2 |
| Founded | 2011 |
| Employees | 1-10 |
| Socials |
Laureate Biopharmaceutical Services Email Formats
Laureate Biopharmaceutical Services uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@patheon.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@patheon.com | 100% |
About Laureate Biopharmaceutical Services
September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees. Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon. Visit our website at www.Patheon.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Laureate Biopharmaceutical Services has never raised funding before.
Frequently asked questions
4.8
40,000 users



